RHON-KLINIKUM AG (DE:RHK)

XETRA:RHK

RHK

RHON-KLINIKUM AG

RESEARCH TOOLSreports

Want to see DE:RHK full AI Analyst Report?

RHON-KLINIKUM AG (RHK) Price & Analysis

0 Followers

RHK Stock Chart & Stats

€12.90

€0.30(1.99%)

At close: Jan 09 4:00 PM EST

€12.90

€0.30(1.99%)

Day’s Range― - ―

52-Week Range€11.20 - €13.40

Previous CloseN/A

Volume1.17K

Average Volume (3M)955.00

Market Cap

€850.12M

Enterprise Value€775.37M

Total Cash (Recent Filing)€346.19M

Total Debt (Recent Filing)€146.87M

Price to Earnings (P/E)21.2

Beta-0.16

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.77%

Share Statistics

EPS (TTM)0.56

Shares Outstanding66,962,470

10 Day Avg. Volume528

30 Day Avg. Volume955

Financial Highlights & Ratios

PEG Ratio-1.23

Price to Book (P/B)0.64

Price to Sales (P/S)0.44

P/FCF Ratio-24.57

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.76

Revenue Forecast (FY)€1.79B

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetThe company’s low leverage and rising equity provide a durable financial cushion that supports operating flexibility and downturn resilience. With total debt reduced and sizable equity, RHÖN-KLINIKUM can absorb temporary cash-flow variability, invest selectively, and access capital without immediate solvency pressure.

Multi-year Revenue RecoveriesRecurring double-digit revenue recoveries in 2023 and 2025 indicate structural patient demand and pricing/reimbursement realization across hospital services. These rebounds suggest the business can regain volume and revenue momentum after setbacks, supporting medium-term topline stability if operational issues are addressed.

Proven Cash-generation CapacityPrior years’ strong operating cash flow shows the underlying hospital network can generate meaningful cash from operations. This historical cash generation demonstrates capacity to self-fund investments and weather cyclical pressures if 2025’s weakness proves temporary and cost conversion recovers.

Bears Say

Sharp EBIT Collapse In 2025A near-total collapse in operating profit signals structural margin pressure or major one-off costs that materially reduce operating leverage. Persistently depressed EBIT undermines reinvestment, raises sensitivity to reimbursement changes, and could force cost restructuring or limit strategic initiatives over the medium term.

Negative Free Cash Flow In 2025A shift to negative free cash flow erodes liquidity and increases reliance on external funding despite low net debt. If negative FCF persists, the company may need to curtail capex, seek financing, or use reserves, reducing strategic optionality and raising refinancing or cost-of-capital risk over the coming quarters.

Thin Margins And Low ROESubdued profitability metrics limit internal funding for growth and reduce buffer against reimbursement cuts or wage inflation. Low ROE and narrow margins mean the business must maintain high utilization and tight cost control to generate acceptable returns, increasing operational leverage to adverse shocks.

RHK FAQ

What was RHON-KLINIKUM AG’s price range in the past 12 months?

RHON-KLINIKUM AG lowest stock price was €11.20 and its highest was €13.40 in the past 12 months.

What is RHON-KLINIKUM AG’s market cap?

RHON-KLINIKUM AG’s market cap is €850.12M.

When is RHON-KLINIKUM AG’s upcoming earnings report date?

RHON-KLINIKUM AG’s upcoming earnings report date is Aug 06, 2026 which is in 57 days.

How were RHON-KLINIKUM AG’s earnings last quarter?

RHON-KLINIKUM AG released its earnings results on May 07, 2026. The company reported €0.19 earnings per share for the quarter, beating the consensus estimate of N/A by €0.19.

Is RHON-KLINIKUM AG overvalued?

According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does RHON-KLINIKUM AG pay dividends?

RHON-KLINIKUM AG pays a Annually dividend of €0.2 which represents an annual dividend yield of 0.77%. See more information on RHON-KLINIKUM AG dividends here

What is RHON-KLINIKUM AG’s EPS estimate?

RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does RHON-KLINIKUM AG have?

RHON-KLINIKUM AG has 66,962,470 shares outstanding.

What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?

RHON-KLINIKUM AG reported an EPS of €0.19 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of RHON-KLINIKUM AG?

Currently, no hedge funds are holding shares in DE:RHK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

RHON-KLINIKUM AG Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

3.04%

Trailing 12-Months

Asset Growth

-1.58%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

RHON-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical and surgical care, including cardiovascular rehabilitation, specialized hand and trauma surgery, neurological and psychosomatic treatments, addiction therapy, ophthalmology, and dentistry. They also address conditions affecting the thoracic region, lungs, and vascular system, offer oncology services, and manage neurological conditions, spinal column and joint issues, as well as heart diseases. The organization operates eight hospitals, providing a total of 5,420 beds or patient slots across five distinct medical locations. RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.